Xiaomin Su

机构：Dalian Medical University, Nankai University, Fudan University, Fudan University Shanghai Cancer Center, Ministry of Education, Pudong Medical Center, Puer University, First Affiliated Hospital of Dalian Medical University, Second Affiliated Hospital of Jilin University · ORCID：0000-0002-1621-4009

发表论文 65 篇 · 总被引 1691 次 · h-index 26

代表论文

• Taking SCFAs produced by Lactobacillus reuteri orally reshapes gut microbiota and elicits antitumor responses (2024 · Journal of Nanobiotechnology · 被引 70)
• AI-powered omics-based drug pair discovery for pyroptosis therapy targeting triple-negative breast cancer (2024 · Nature Communications · 被引 53)
• Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context (2023 · Advanced Science · 被引 48)
• Oral probiotics microgel plus Galunisertib reduced TGF-β blockade resistance and enhanced anti-tumor immune responses in colorectal cancer (2024 · International Journal of Pharmaceutics · 被引 26)
• Extracellular Vehicles from Commensal Skin Malassezia restricta Inhibit Staphylococcus aureus Proliferation and Biofilm Formation (2024 · ACS Infectious Diseases · 被引 16)
• Synergistic gentamicin-photodynamic therapy against resistant bacteria in burn wound infections (2022 · Photodiagnosis and Photodynamic Therapy · 被引 14)